We are thrilled to celebrate a monumental milestone for our national health system. The recently announced $1.46 billion health cooperation agreement between the governments of Ethiopia and the United States marks a transformative chapter for our country.
This historic commitment is more than a financial investment; it is a validation of the tireless work being done to ensure every citizen has access to quality healthcare.
Validating a Decade of Impact
For REACH Ethiopia, this agreement resonates deeply with our decade-long mission to combat TB and build resilient community health structures. Our journey has always been defined by a “people-first” approach, and this bilateral cooperation provides the fuel to scale that impact even further.
A Legacy of Innovation
REACH Ethiopia has consistently been at the forefront of health technology and community-based care. Our proven track record includes:
- Pioneering Diagnostics: We were the first to utilize GeneXpert machines in Ethiopia, revolutionizing the speed and accuracy of TB diagnosis.
- AI-Powered Solutions: We have introduced ultra-portable digital X-rays powered by Artificial Intelligence, bringing high-tech screening to the most remote areas.
- Community-Led Prevention: Our core strength lies in our community-based TB prevention and control activities, ensuring that care reaches the doorstep of those who need it most.
Our dedication to excellence was globally recognized when we were awarded the prestigious Kochon Prize, an honor that continues to drive our pursuit of a TB-free Ethiopia.
Looking Ahead: Strength in Partnership
We fully support this bilateral cooperation and stand ready to work hand-in-hand with the Ministry of Health. By leveraging this new support, we aim to accelerate innovation and strengthen the health systems that protect our nation.
As we move forward into this new chapter, our promise remains unchanged: We will ensure that no one is left behind in our journey to #EndTB.
